You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 8, 2025

Drug Price Trends for DIALYVITE TABLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DIALYVITE TABLET

Average Pharmacy Cost for DIALYVITE TABLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DIALYVITE TABLET 10542-0010-10 0.17084 EACH 2025-01-22
DIALYVITE TABLET 10542-0010-10 0.16982 EACH 2024-12-18
DIALYVITE TABLET 10542-0010-10 0.17109 EACH 2024-11-20
DIALYVITE TABLET 10542-0010-10 0.16803 EACH 2024-10-23
DIALYVITE TABLET 10542-0010-10 0.16540 EACH 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Dialyvite Tablets

Introduction

Dialyvite tablets are a range of nutritional supplements designed primarily for patients undergoing renal dialysis. These products are formulated to address the specific nutritional needs of this patient group, providing essential vitamins, minerals, and other nutrients. Here, we will delve into the market analysis and price projections for Dialyvite tablets.

Market Context

The market for nutritional supplements, particularly those targeted at patients with specific medical conditions like renal dialysis, is niche but significant. The demand for these products is driven by the growing number of patients requiring dialysis and the need for comprehensive nutritional support to manage their health effectively.

Global Pricing Trends

The pharmaceutical market, including nutritional supplements, is characterized by significant price disparities across different regions. According to the ASPE report, prices in the U.S. are substantially higher than in other OECD countries and the rest of the world. This trend is relevant for Dialyvite tablets, as they are primarily marketed in the U.S.[3].

Product Variants and Pricing

Dialyvite tablets come in several formulations, each with its own pricing structure.

Dialyvite with Zinc Rx

This variant is a multivitamin with minerals, including zinc, and is commonly used for vitamin and mineral supplementation. The cost for a supply of 100 tablets is around $28.59, which translates to approximately $0.29 per unit[2].

Dialyvite Chewable Probiotic

This product is focused on digestive health and contains two viable probiotic strains. The pricing varies by quantity: 30 tablets for $8.75, 60 tablets for $14.95, and 120 tablets for $28.75[1].

Dialyvite 800

This formulation is rich in vitamins and minerals, including folic acid, and is designed for renal dialysis patients. The price is $10.45 per 100-tablet bottle and $16.75 per 180-tablet bottle[5].

Market Size and Growth

The market for renal dialysis-related nutritional supplements is growing due to an increasing patient population. However, the overall market size is influenced by several factors, including the availability of alternative products, insurance coverage, and patient assistance programs.

Retail vs. Non-Retail Markets

The sales revenues for pharmaceuticals, including nutritional supplements, have shown different trends in retail and non-retail markets. In the U.S., sales revenues grew significantly in both retail and non-retail markets, while other regions experienced contractions in the retail market but growth in the non-retail sector[3].

Price Projections

Given the current market trends and pricing structures, here are some key points to consider for price projections:

Current Pricing

  • Dialyvite with Zinc Rx: Approximately $0.29 per unit for a 100-tablet supply.
  • Dialyvite Chewable Probiotic: Ranges from $0.29 to $0.24 per unit depending on the quantity purchased.
  • Dialyvite 800: $0.10 per unit for a 100-tablet bottle.

Future Trends

  • Price Increases: The U.S. pharmaceutical market has seen an average price increase of 14% between 2017 and 2022. This trend is likely to continue, albeit at a potentially slower rate due to regulatory and market pressures[3].
  • Market Competition: The presence of alternative products and generic options could influence pricing. However, Dialyvite's specific formulation and target market may help maintain its pricing structure.
  • Patient Assistance Programs: While there are no specific patient assistance programs for Dialyvite, the availability of such programs for similar products could impact pricing strategies.

Regulatory and Economic Factors

Several factors can impact the pricing of Dialyvite tablets:

Regulatory Environment

Changes in regulatory policies, especially those related to pharmaceutical pricing and reimbursement, can significantly affect the market. For instance, policies aimed at reducing healthcare costs could lead to price caps or increased competition from generic alternatives.

Economic Conditions

Economic downturns or changes in healthcare spending can influence consumer behavior and demand for nutritional supplements. However, the essential nature of these products for renal dialysis patients may mitigate some of these effects.

Consumer and Patient Perspectives

Patient needs and preferences play a crucial role in the market for Dialyvite tablets.

Nutritional Needs

Renal dialysis patients have specific nutritional requirements that Dialyvite tablets are designed to meet. The product's effectiveness in addressing these needs will continue to drive demand.

Cost Sensitivity

While the products are essential, cost remains a significant factor. Patients and healthcare providers may seek more affordable alternatives, which could pressure prices downward.

Key Takeaways

  • Market Niche: Dialyvite tablets serve a specific and critical need for renal dialysis patients.
  • Pricing Structure: Current prices vary by product variant, with a general trend of higher prices in the U.S. compared to other regions.
  • Future Trends: Expected price increases due to market trends, but potential regulatory and competitive pressures could influence pricing.
  • Regulatory and Economic Factors: Changes in regulatory policies and economic conditions can impact pricing and demand.
  • Patient Needs: The essential nature of these products for renal dialysis patients ensures ongoing demand.

FAQs

What is the primary use of Dialyvite tablets?

Dialyvite tablets are primarily used to improve the nutritional status of renal dialysis patients by providing essential vitamins and minerals.

How much do Dialyvite tablets cost?

The cost varies by product variant, but for example, Dialyvite with Zinc Rx costs around $28.59 for a 100-tablet supply, and Dialyvite 800 costs $10.45 for a 100-tablet bottle.

Are there any patient assistance programs for Dialyvite tablets?

Currently, there are no specific patient assistance programs for Dialyvite tablets, but healthcare providers may have information on available programs in their area[2].

Why are prices for Dialyvite tablets higher in the U.S. compared to other regions?

Prices in the U.S. are generally higher due to a combination of higher base prices and a drug mix that skews towards more expensive compounds[3].

What factors could influence future price projections for Dialyvite tablets?

Future price projections could be influenced by regulatory changes, economic conditions, market competition, and patient assistance programs.

Sources

  1. Dialyvite Chewable Probiotic - Hillestad Pharmaceuticals USA.
  2. Dialyvite with Zinc Rx Prices - Drugs.com.
  3. International Market Size and Prices - ASPE.
  4. Dialyvite: Package Insert / Prescribing Information - Drugs.com.
  5. Dialyvite 800 - Hillestad Pharmaceuticals USA.

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.